West Pharmaceutical Price Target, which fell from BOFA’s $285 to $280, has been reduced to $280
Bofa has dropped the company’s Price target West Pharmaceutical (WST) Maintains stock purchase ratings from $285 to $280. The sentiment of life sciences and diagnostic tools, and contract research institutes, has been “more negative” in revenue, given that these companies are “sitting at the intersection of many policy changes.” Trump “Management,” including headwinds from NIH budget cuts and global tariffs, particularly the broader macro concerns around China, telling investors in a group preview.
First published fly – The ultimate source of financial news that moves to the market in real time. Try it now >>
See today’s best performance stocks in Tipranks >>
Read more about WST: